145 related articles for article (PubMed ID: 26030859)
21. [High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs].
Zhao J; Zhang XG; Chen R; Bi H; Wang X; Liu GW; Yao DX; Zong Y; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):149-51. PubMed ID: 21863645
[TBL] [Abstract][Full Text] [Related]
22. Screening for Cervical Cancer: New Tools and New Opportunities.
Learman LA; Garcia FAR
JAMA; 2018 Aug; 320(7):647-649. PubMed ID: 30140859
[No Abstract] [Full Text] [Related]
23. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
24. The BAC recommended code of practice for cytology laboratories participating in the UK cervical screening programmes 2015 - an introduction.
Smart LM
Cytopathology; 2016 Feb; 27(1):5-7. PubMed ID: 26818037
[No Abstract] [Full Text] [Related]
25. [Cervical cancer screening and the place of the HPV test in 2012].
Bosch FX; Bergeron C
Ann Pathol; 2012 Nov; 32(5 Suppl):S22-3. PubMed ID: 23127928
[No Abstract] [Full Text] [Related]
26. Changes on the horizon for cervical cancer screening.
Isidean SD; Shinder GA
Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
[No Abstract] [Full Text] [Related]
27. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
28. Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks.
Austin RM
Diagn Cytopathol; 2010 Nov; 38(11):783-7. PubMed ID: 20607804
[No Abstract] [Full Text] [Related]
29. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
30. Triage of high-risk HPV positive women in cervical cancer screening.
Ebisch RM; Siebers AG; Bosgraaf RP; Massuger LF; Bekkers RL; Melchers WJ
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1073-85. PubMed ID: 27598683
[TBL] [Abstract][Full Text] [Related]
31. Multimodality screening and prevention of cervical cancer in sub-Saharan Africa: a collaborative model.
Chinn J; Tewari KS
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):28-35. PubMed ID: 31804231
[TBL] [Abstract][Full Text] [Related]
32. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
33. HPV Testing in Resource-Limited Settings: How Can We Reach the Next Level of Cervical Cancer Screening in Latin America and the Caribbean?
Randall TC; Salicrup LA; Luciani S; Trimble EL
Oncologist; 2015 Oct; 20(10):1101-4. PubMed ID: 26330459
[TBL] [Abstract][Full Text] [Related]
34. [Liquid-based cervical cytology ThinPrep screening in Hungary].
Bak M; Séberné Éll M; Bóka M; Veleczki Z; Nyári T; Pete I; Szentirmay Z
Orv Hetil; 2014 May; 155(18):708-14. PubMed ID: 24776385
[TBL] [Abstract][Full Text] [Related]
35. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
36. Screening for cervical cancer and human papilloma virus: Indian context.
Deodhar KK
Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
38. Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening.
Ogden SN; Glanz K; Schapira MM; Bocage C; Eriksen W; Rendle KA
J Gen Intern Med; 2020 Mar; 35(3):956-958. PubMed ID: 31313121
[No Abstract] [Full Text] [Related]
39. How Many Human Papillomavirus Types Do We Need to Screen For?
Sundström K; Dillner J
J Infect Dis; 2021 May; 223(9):1510-1511. PubMed ID: 32941611
[No Abstract] [Full Text] [Related]
40. High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply.
Dang L; Qiao Y; Lang J
JAMA Oncol; 2021 Jul; 7(7):1067-1068. PubMed ID: 33914043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
